Timothy Voorhees

29PUBLICATIONS
177CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 24, 2026
Incidence of clinically significant chemotherapy induced nausea and vomiting with brentuximab vedotin and AVD in comparison with ABVD using standard anti-emetic prophylaxis.

|Jul 14, 2026
Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22.

|Jul 10, 2026
Longitudinal plasma neurofilament light chain and patient-reported outcomes as complementary markers of vincristine-associated peripheral neuropathy in adults with lymphoma: a cohort study.

|Jul 08, 2026
Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CART.

|Mar 24, 2026
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Matthew Hamby, Brian L Egleston, Zachary A K Frosch

|Feb 26, 2026
Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study.

John Sharp, Paolo Strati, Subodh Bhatta

Pageof 5

Frequent Collaborators

15 joint publications

Narendranath Epperla

8 joint publications

Natalie Sophia Grover

6 joint publications

Yazeed Sawalha

5 joint publications

David Bond